Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases

Detalles Bibliográficos
Autores principales: Richette, Pascal, Allez, Matthieu, Descamps, Vincent, Perray, Lucas, Pilet, Simon, Latourte, Augustin, Maravic, Milka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/
https://www.ncbi.nlm.nih.gov/pubmed/34314887
http://dx.doi.org/10.1016/j.jbspin.2021.105253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/
https://www.ncbi.nlm.nih.gov/pubmed/34314887
http://dx.doi.org/10.1016/j.jbspin.2021.105253

Ejemplares similares